UniMed UniHealth

What UniMed UniHealth does

UniMed UniHealth (doing business as Unimed Healthcare) operates as a KKR-controlled healthcare platform that uses Baby Memorial Hospital in Kozhikode, Kerala as its anchor asset for consolidating hospital operators across southern India. KKR acquired a controlling stake in Baby Memorial Hospital in July 2024 for approximately ₹2,500 crore, and the platform has since executed two material acquisitions: Meitra Hospitals in Kerala for ₹1,200 crore in 2025 and a 60% stake in Hyderabad-based Star Hospitals for ₹1,800 crore (₹3,000 crore enterprise value), with the latter approved by the Competition Commission of India in April 2026.

The company's business model is direct hospital-service delivery through owned and majority-owned facilities, generating revenue through inpatient and outpatient medical care, specialized treatments, and ancillary clinical services. Customer segments are patients seeking healthcare in southern India, distributed across the Baby Memorial, Meitra, and Star networks in Kerala and Telangana. Pricing is quote-based and varies by treatment type, room category, and service line, consistent with private multi-specialty hospital economics in India.

Strategically, KKR has signaled that the platform may either be merged with other hospital platforms or taken public, positioning UniMed UniHealth as an exit-oriented roll-up vehicle. The headcount range (501–1,000) and firmographics metadata in the source set do not align with the detailed KKR-platform narrative and should be treated cautiously; the analytical profile above is grounded in the detailed transactional evidence. No technology stack, AI capabilities, or product lines beyond hospital services are disclosed.

Name

UniMed UniHealth

Website

https://unimedunihealth.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

501–1,000 employees

Short description

UniMed UniHealth (Unimed Healthcare) is a KKR-controlled hospital consolidation platform anchored by Baby Memorial Hospital in Kerala, expanding across southern India through acquisitions of Meitra Hospitals and Star Hospitals.

Ownership category

akta.pro rank

Product category

Generic Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

akta.pro secondary industries

Specialty Pharmaceutical Distributors (HLAIAJAB), Medical Supplies & Consumables Wholesale (Non-Device) (CRAOAHAE)

Keywords

• Generic pharmaceutical manufacturing
• Therapeutic medicines supply
• Pharmaceutical products
• Medicine manufacturing
• Pharmaceutical wholesale

Headquarters

HQ city

Dhaka

HQ country

Bangladesh

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel

Revenue model

1. Hospital Healthcare Services: Hospital services revenue through operation of healthcare facilities providing medical care to patients

Go-to-market motion1 record

Distribution channels1 record

Core offering

UniMed UniHealth manufactures and supplies a wide range of therapeutic medicines and generic pharmaceutical products. The company produces pharmaceutical formulations for healthcare distribution within Bangladesh, supported by 501-1000 employees and operations headquartered in Dhaka.

Differentiator

Problem solved

Functional benefit

Products and services

• Therapeutic medicines A range of therapeutic medicines manufactured and supplied by UniMed UniHealth for healthcare buyers in Bangladesh, including distributors, pharmacies, and hospitals.
• Generic pharmaceutical products A range of generic pharmaceutical products manufactured and supplied by UniMed UniHealth for healthcare buyers in Bangladesh, including distributors, pharmacies, and hospitals.

Named customers2 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators5 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• Square Pharmaceuticals: Bangladesh's largest pharmaceutical manufacturer, also producing generics and therapeutic medicines. Closest direct comparable to UniMed UniHealth by geography, product mix, and manufacturing-plus-distribution model.
• Beximco Pharmaceuticals: Major Bangladeshi generic pharma manufacturer with both domestic and export operations. Comparable to UniMed UniHealth in therapeutic breadth, generic focus, and Bangladesh-headquartered manufacturing footprint.
• Incepta Pharmaceuticals: Bangladesh-based manufacturer of generics, biologics, and therapeutic medicines with strong export orientation. Closely matches UniMed UniHealth's manufacturer-and-supplier profile and product category breadth.
• Renata Limited: Bangladesh pharma manufacturer with animal health and human generics portfolios. Comparable to UniMed UniHealth in being a Bangladesh-headquartered, multi-category pharmaceutical producer.
• ACI Limited: Diversified Bangladeshi conglomerate with a sizable pharmaceutical manufacturing arm. Comparable to UniMed UniHealth as a domestic pharma producer operating in therapeutic and generic categories.
• Eskayef Pharmaceuticals: Bangladesh-based generics manufacturer with growing export presence. Comparable to UniMed UniHealth in scale, product mix, and South Asian manufacturing-distribution model.
• Healthcare Pharmaceuticals: Bangladesh pharmaceutical manufacturer focused on generics and specialty therapeutics. Direct comparable on geography, regulatory environment, and generic-driven revenue mix.

Broad incumbents

• Sun Pharmaceutical Industries: India's largest generic pharmaceutical manufacturer with global operations. Broader incumbent whose generic portfolio and South Asia footprint overlap with UniMed UniHealth's competitive set, particularly in export markets.
• Dr. Reddy's Laboratories: Global Indian generic pharma major with broad therapeutic coverage. Comparable as a large-scale generics competitor UniMed UniHealth would face in both Bangladesh and any export ambitions.
• Cipla: Large Indian generic manufacturer with strong presence across emerging markets including South Asia. Comparable as a regional generics competitor and a benchmark for export-oriented growth in similar therapeutic categories.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks4 records

Key highlights4 records

Customer concentration

• Xx.com/unimedunihealth

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about UniMed UniHealth